Literature DB >> 2738879

Synthesis and antitumor activity of ribavirin imidates. A new facile synthesis of ribavirin amidine (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride).

G D Kini1, R K Robins, T L Avery.   

Abstract

Methyl 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboximidate (4) and ethyl 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidate (6) were synthesized and tested for antitumor and antiviral activity. A new facile synthesis of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride (5), starting with imidate 4, was also developed. The imidates 4 and 6 differed greatly in solubility and dosing requirements. Even so, both compounds exhibited significant activity in vivo against murine leukemia L1210. Nontoxic dosing with 4 also significantly diminished Friend leukemia induced splenomegaly. In contrast, neither imidate was active in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2738879     DOI: 10.1021/jm00127a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.

Authors:  E De Clercq; M Cools; J Balzarini; R Snoeck; G Andrei; M Hosoya; S Shigeta; T Ueda; N Minakawa; A Matsuda
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors.

Authors:  Xin Teng; Heather Keys; Junying Yuan; Alexei Degterev; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2008-04-25       Impact factor: 2.823

Review 3.  Advance of structural modification of nucleosides scaffold.

Authors:  Xia Lin; Chunxian Liang; Lianjia Zou; Yanchun Yin; Jianyi Wang; Dandan Chen; Weisen Lan
Journal:  Eur J Med Chem       Date:  2021-01-30       Impact factor: 6.514

4.  Development of Novel Triazolo-Thiadiazoles from Heterogeneous "Green" Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors.

Authors:  C P Baburajeev; Chakrabhavi Dhananjaya Mohan; Hanumappa Ananda; Shobith Rangappa; Julian E Fuchs; Swamy Jagadish; Kodappully Sivaraman Siveen; Arunachalam Chinnathambi; Sulaiman Ali Alharbi; M E Zayed; Jingwen Zhang; Feng Li; Gautam Sethi; Kesturu S Girish; Andreas Bender; Kanchugarakoppal S Rangappa
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.